PGP and ovarian carcinoma: Procyanidine reverses P-gp associated MDR by inhibiting the function and expression of P-gp through down-regulation of NF-κB activity and MAPK/ERK pathway mediated YB-1 nuclear translocation in MDR human ovarian cancer cell line (A2780/T) [171,172].